GME vs GSK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 21, 2026

GME

54.5
AI Score
VS
GSK Wins

GSK

58.5
AI Score

Investment Advisor Scores

GME

55score
Recommendation
HOLD

GSK

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GME GSK Winner
Forward P/E 28.2486 21.5054 GSK
PEG Ratio 0.3059 19.3811 GME
Revenue Growth 14.1% 1.5% GME
Earnings Growth 633.3% 8.4% GME
Tradestie Score 54.5/100 58.5/100 GSK
Profit Margin 20.4% 17.8% GME
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, GSK is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.